Bard Financial Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,010
Closed -$280K 328
2022
Q4
$280K Sell
10,010
-400
-4% -$10.2K 0.02% 251
2022
Q3
$244K Sell
10,410
-840
-7% -$25.4K 0.02% 253
2022
Q2
$380K Sell
11,250
-805
-7% -$28.2K 0.03% 218
2022
Q1
$421K Buy
12,055
+1,750
+17% +$59.8K 0.03% 214
2021
Q4
$314K Buy
10,305
+605
+6% +$19.7K 0.03% 229
2021
Q3
$318K Sell
9,700
-175
-2% -$5.6K 0.03% 220
2021
Q2
$299K Buy
+9,875
New +$325K 0.03% 222

Other funds holding OGN

Bard Financial Services's OGN Position: Q1 2023 in Review

Bard Financial Services sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 10,010 shares — an estimated $280K sold.

Bard Financial Services first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $421K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Bard Financial Services reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Bard Financial Services sold 10,010 Organon & Co shares in Q1 2023, an estimated $280K.
  • Bard Financial Services first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Bard Financial Services's Organon & Co position peaked at $421K in Q1 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Bard Financial Services's 13F filing for Q1 2023, filed 26 Apr 2023.